ADAPTED POSTERS
Titles of posters presented by ADAPTED researchers. For more information please contact the ADAPTED Project office at adapted@modus.ltd.
Development of a fast and versatile method for genome-wide association studies of longitudinal data
Presented by: Luca Kleineidam (UKK)
Conference: Alzheimer's Association International Conference (AAIC) 2020
Proteomic, metabolomic, and transcriptomic examination of APOE transgenic mice
Presented by: Eric Mohler (AbbVie)
Conference: Alzheimer's Association International Conference (AAIC) 2020
Identification of ApoE phenotypes in microglia and neurons derived from isogenic hiPS cells- a study of the IMI ADAPTED consortium
Presented by: Lamiaa Bahnassawy (AbbVie)
Conference: Alzheimer's Association International Conference (AAIC) 2020
Multi-layer OMICS characterisation of APOE modulated isogenic hiPSCs elucidate cell type specific mechanisms modified by APOE - a study of the IMI ADAPTED consortium
Presented by: Janina Ried (AbbVie)
Conference: Alzheimer's Association International Conference (AAIC) 2020
APOE and sex-stratified genome-wide meta-analyses of Alzheimer's disease
Presented by: Maria Saez (CAEBi)
Conference: Alzheimer's Association International Conference (AAIC) 2020
Candidates genes and pathways from ADAPTED Stage I integrative analysis
Presented by: Laura Madrid (CAEBi)
Conference: IMI 10th Anniversary Scientific Symposium
TMT-based comparison of ApoE ε4 and ε3 mouse brain samples – proteomics insights into the aetiology of Alzheimer’s disease
Presented by: Armel Nicolas (DCB)
Conference: The Austrian Metabolomics and Proteomics Conference 2018
Looking for therapeutic entry points for Alzheimer’s disease: lessons learned from agnostic trans-co-regulatory network analyses of APOE, TREM2, PLCG2 and ABI3 loci
Presented by: Agustín Ruiz (FACE)
Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.
Systematic APOE genotype-stratified analysis of human omics data - a study from the IMI ADAPTED project
Presented by: Margaretha Bakker (Abbvie)
Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.
APOE-ε4 modulates levels of ω-3 and ω-6 fatty acids in Alzheimer’s disease dementia
Presented by: Holger Wagner (UKB), Alfredo Ramirez (UKB).
Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.
Modeling Alzheimer’s disease pathophysiology using isogenic human APOE iPSC-derived neural cells
Presented by: Lamiaa Bahnassawy (AbbVie)
Conference: ISSCR Annual Meeting 2018, Melbourne, Australia
Cerebrospinal fluid and plasma levels of Lysophosphatidic acids (LPAs) associate with cerebrospinal fluid Aβ-42 and P-tau
Presented by: Shahzad Ahmad (EMC)
Conference: 2nd Meeting of Society of CSF analysis and clinical neurochemistry, Amsterdam, NL.